Body-wide expression profiles for EPHA2 (Fig. 2A), VEGFC (Fig. 3A), and ERBB3 (Fig. 4A) indicated the most selective overexpression in malignant connective tissues, when compared to all other pediatric cancer and healthy normal tissues. The gene discussed is EPHA2; the disease is cancer.